On January 17th, Dian Diagnostics and the Gulf Medical University of the United Arab Emirates signed a letter of intent for cooperation in Hangzhou. The two parties will collaborate on talent exchange, channel construction, research cooperation, and business transformation, aiming to jointly promote innovation and development in medical services in the Middle East and globally.                                              

signing ceremony

The President of Gulf Medical University, Hossam Hamdy, and Guo Sanhui, Senior Vice President of Dian Diagnostics, represented their respective sides in signing the agreement. The signing ceremony was witnessed by Majid Essa Al Ghurair, Director and Vice Chairman of Al Ghurair Investment Group, and Chairman of Dian Diagnostics, Chen Haibin.

Professor Hossam Hamdy mentioned that since the outbreak of the COVID-19 pandemic, the Middle East has highly recognized China's biomedicine technology. The industry actively seeks cooperation with Chinese companies in the field of biomedicine. Gulf Medical University trusts the technology and strength of Dian Diagnostics and hopes that this letter of intent for cooperation is the starting point for extensive collaboration in various fields. The aim is to make a greater contribution to innovation and progress in the field of medicine.

Sheng Xia, Deputy Director of International Business at Dian Diagnostics, introduced the achievements of Dian Diagnostics in international strategic layout, technological innovation, and talent training planning. He mentioned that Dian Diagnostics has been closely following the development trends and demands of the international market. Through measures such as product promotion and establishing overseas laboratories, the company deepens its international business strategy. The goal is to work together with Gulf Medical University, using a "product + service" dual-drive approach, striving to introduce its distinctive precision center model, laboratory services, and self-developed product solutions to the Middle East market. The collaboration aims to enhance the construction of health systems in the UAE and the Middle East, contributing to the development of the medical industry in the region.